
India Moves Closer to Affordable Weight-Loss Therapy as Sun Pharma Wins DCGI Nod for Semaglutide
Previous articleDelhi High Court Allows Sale of Zydus's Nivolumab Biosimilar Ahead of Patent Expiry
Next article Central Government’s New Move Against AMR: Blue Strip Labelling on Antibiotics
Next article Central Government’s New Move Against AMR: Blue Strip Labelling on Antibiotics
